GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arterra Bioscience SpA (MIL:ARBS) » Definitions » ROE % Adjusted to Book Value

Arterra Bioscience SpA (MIL:ARBS) ROE % Adjusted to Book Value : 7.17% (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Arterra Bioscience SpA ROE % Adjusted to Book Value?

Arterra Bioscience SpA's ROE % for the quarter that ended in Jun. 2024 was 9.68%. Arterra Bioscience SpA's PB Ratio for the quarter that ended in Jun. 2024 was 1.35. Arterra Bioscience SpA's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 7.17%.


Arterra Bioscience SpA ROE % Adjusted to Book Value Historical Data

The historical data trend for Arterra Bioscience SpA's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arterra Bioscience SpA ROE % Adjusted to Book Value Chart

Arterra Bioscience SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 5.08 6.36 6.17 10.35 10.04

Arterra Bioscience SpA Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.03 10.63 3.19 15.76 7.17

Competitive Comparison of Arterra Bioscience SpA's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Arterra Bioscience SpA's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arterra Bioscience SpA's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arterra Bioscience SpA's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Arterra Bioscience SpA's ROE % Adjusted to Book Value falls into.


;
;

Arterra Bioscience SpA ROE % Adjusted to Book Value Calculation

Arterra Bioscience SpA's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.14% / 1.01
=10.04%

Arterra Bioscience SpA's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.68% / 1.35
=7.17%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arterra Bioscience SpA ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Arterra Bioscience SpA's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Arterra Bioscience SpA Business Description

Traded in Other Exchanges
N/A
Address
via Benedetto Brin, 69, Napoli, ITA, 80142
Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.

Arterra Bioscience SpA Headlines

No Headlines